As health systems enter 2026, digital transformation is no longer measured by how many tools are deployed or how quickly they go live. With capital constrained and margins still under pressure, executive teams are becoming far more disciplined about how they define success and far less tolerant of technology that fails to change day-to-day work.
Across interviews with clinical, operational, revenue cycle and digital leaders, a clear pattern has emerged: the most trusted signals of ROI are behavioral, not technical. Here are 10 things health system C-suites are watching most closely this year, based on interviews with 55 health system IT, clinical and revenue cycle leaders.
1. Deep and broad adoption. C-suites still care about adoption, but they are moving beyond surface-level usage metrics. Leaders want to see whether clinicians and staff are using a tool’s full functionality rather than defaulting to its most basic features. Shallow adoption often signals missed training, poor workflow fit or cultural resistance, all of which limit ROI. In 2026, executives increasingly view depth of use as a proxy for whether a tool is truly embedded in daily work.
2. Whether tools are used correctly to affect outcomes. In 2026, C-suites are scrutinizing whether digital tools are used at the precise moment they are designed to influence behavior, not before or after the fact. Executives are tracking the percentage of eligible encounters where a tool is activated when a real decision is being made — such as an order placed, a discharge finalized or a handoff completed. Usage that occurs outside the decision window may inflate adoption metrics but fails to change outcomes. Leaders increasingly view “used correctly when it mattered” as a prerequisite for any downstream value.
3. Sustained use after the excitement fades. A strong launch no longer convinces C-suites that a digital investment is successful. Executives are closely tracking whether usage holds steady weeks and months after go-live, once novelty wears off. Drop-off often reveals hidden friction, training gaps or workflow misalignment that dashboards don’t initially show. Durable, consistent use without reminders or mandates has become a leading indicator of long-term value.
4. First-pass success instead of downstream cleanup. Revenue cycle and clinical leaders are shifting attention upstream, away from lagging indicators that reflect rework. Clean claims, accurate documentation and correct authorizations on the first pass signal that frontline behavior has changed. These metrics expose whether technology is preventing problems rather than fixing them later. In 2026, executives increasingly see first-pass success as a clearer link between digital tools and financial performance.
5. Fewer human touches and workarounds. C-suites are watching whether digital investments quietly reduce manual intervention. When staff stop overriding systems, escalating exceptions or maintaining shadow workflows, trust in the technology has taken hold. Leaders see fewer human touches as a sign that the tool has become the preferred path, not the mandated one. In many cases, declining rework tells a more honest story than rising utilization numbers.
6. Time returned to clinicians and staff. Time has become one of the most valuable currencies in healthcare. Executives are tracking documentation time, turnaround times, after-hours EHR use and task completion speed to understand whether technology is giving time back. Tools that measurably reduce cognitive burden and administrative load are viewed as changing behavior in meaningful ways. In 2026, returning time is often as compelling to C-suites as generating revenue.
7. Workflow friction — or the lack of it. C-suites are increasingly sensitive to signs of friction at the front line. Step-bypass rates, delays, informal workarounds and complaints signal that technology is adding complexity instead of removing it. When tools integrate cleanly and fade into the background, adoption tends to persist without enforcement. Leaders now see low friction as a prerequisite for sustainable digital transformation.
8. Proof of measurable impact. Even when tools are used at the right time, C-suites are asking a tougher question: did that behavior change actually move the needle? Executives are pairing adoption and execution metrics with downstream indicators such as throughput, access, length of stay, denial rates, quality measures or cost performance. High utilization without corresponding improvement now signals a workflow or design problem, not success. In 2026, sustained investment depends on clear evidence that changed behavior is translating into operational, clinical or financial results.
9. Metrics defined before implementation. C-suites are becoming more disciplined about defining success before a tool is deployed. Rather than searching for a universal KPI, leaders are tailoring metrics to the problem being solved, the audience using the tool and its level of risk. This approach helps organizations avoid post hoc justifications and shifting goalposts. Clear success criteria upfront also strengthen governance and investment decisions.
10. Cultural signals that technology has truly “stuck.” Finally, executives are watching for cultural indicators that dashboards can’t capture. When teams default to new workflows without prompting, stop referring to the tool as a “project,” and speak its language naturally, behavior has shifted. Leaders also pay attention to whether work feels lighter and less reactive at the front line. In 2026, these qualitative signals often confirm what metrics alone cannot.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.